Asklerol 3% Injection (Polidocanol 30 mg) – 2 ml Injection

About this Medicine

Asklerol 3% Injection, containing the active ingredient Polidocanol, is a specialized pharmaceutical product designed for the targeted treatment of certain varicose and spider veins. As a potent sclerosing agent, Polidocanol works by causing a controlled inflammatory reaction within the inner lining (endothelium) of the targeted vein. This irritation leads to the vein walls swelling, sticking together, and eventually closing off. Over time, the treated vein transforms into scar tissue, which is then reabsorbed by the body, causing the visible vein to fade and disappear. This minimally invasive procedure, known as sclerotherapy, is performed by a qualified healthcare professional directly into the problematic vein. Asklerol 3% Injection is particularly effective for managing uncomplicated spider veins (telangiectasias), reticular veins, and small, uncomplicated varicose veins, primarily those located below the knee. The goal of treatment extends beyond cosmetic improvement, often providing relief from associated symptoms such as aching, heaviness, itching, and burning sensations that can accompany these venous conditions. Before undergoing treatment with Asklerol 3% Injection, patients will undergo a thorough medical evaluation to assess their suitability for sclerotherapy and to rule out any underlying conditions that might contraindicate its use. This comprehensive assessment ensures that Asklerol 3% Injection is an appropriate and safe option for the individual's specific vein concerns. Treatment typically involves a series of injections, tailored to the patient's needs, to achieve optimal results. It is a key component in a multi-faceted approach to venous disease management, aiming to restore both the aesthetic appeal and comfort of the affected areas. Always consult with a vascular specialist or dermatologist to determine if Asklerol 3% Injection is right for your condition.